Skip to main content
NCBI home page
Journal of the Royal Society of Medicine logoLink to Journal of the Royal Society of Medicine
. 1989;82(Suppl 16):26–31.

Cor pulmonale in cystic fibrosis.

M H Götz 1, O C Burghuber 1, U Salzer-Muhar 1, W Wolosczuk 1, M Weissel 1, E Hartter 1
PMCID: PMC1291916  PMID: 2657052

Full text

PDF
26

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allen H. D., Taussig L. M., Gaines J. A., Sahn D. J., Goldberg S. J. Echocardiographic profiles of the long-term cardiac changes in cystic fibrosis. Chest. 1979 Apr;75(4):428–433. doi: 10.1378/chest.75.4.428. [DOI] [PubMed] [Google Scholar]
  2. Ashutosh K., Mead G., Dunsky M. Early effects of oxygen administration and prognosis in chronic obstructive pulmonary disease and cor pulmonale. Am Rev Respir Dis. 1983 Apr;127(4):399–404. doi: 10.1164/arrd.1983.127.4.399. [DOI] [PubMed] [Google Scholar]
  3. Benson L. N., Newth C. J., DeSouza M., Lobraico R., Kartodihardjo W., Corkey C., Gilday D., Olley P. M. Radionuclide assessment of right and left ventricular function during bicycle exercise in young patients with cystic fibrosis. Am Rev Respir Dis. 1984 Dec;130(6):987–992. doi: 10.1164/arrd.1984.130.6.987. [DOI] [PubMed] [Google Scholar]
  4. Brownlee J. R., Beekman R. H., Rosenthal A. Acute hemodynamic effects of nifedipine in infants with bronchopulmonary dysplasia and pulmonary hypertension. Pediatr Res. 1988 Aug;24(2):186–190. doi: 10.1203/00006450-198808000-00009. [DOI] [PubMed] [Google Scholar]
  5. Burghuber O. C., Salzer-Muhar U., Götz M. Right ventricular contractility is preserved in patients with cystic fibrosis and pulmonary artery hypertension. Scand J Gastroenterol Suppl. 1988;143:93–98. doi: 10.3109/00365528809090225. [DOI] [PubMed] [Google Scholar]
  6. Canny G. J., de Souza M. E., Gilday D. L., Newth C. J. Radionuclide assessment of cardiac performance in cystic fibrosis. Reproducibility and effect of theophylline on cardiac function. Am Rev Respir Dis. 1984 Nov;130(5):822–826. doi: 10.1164/arrd.1984.130.5.822. [DOI] [PubMed] [Google Scholar]
  7. Chambers J. B., Monaghan M. J., Jackson G. Echocardiography. BMJ. 1988 Oct 29;297(6656):1071–1076. doi: 10.1136/bmj.297.6656.1071. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Coates A. L., Desmond K., Asher M. I., Hortop J., Beaudry P. H. The effect of digoxin on exercise capacity and exercising cardiac function in cystic fibrosis. Chest. 1982 Nov;82(5):543–547. doi: 10.1378/chest.82.5.543. [DOI] [PubMed] [Google Scholar]
  9. Currie P. J., Seward J. B., Chan K. L., Fyfe D. A., Hagler D. J., Mair D. D., Reeder G. S., Nishimura R. A., Tajik A. J. Continuous wave Doppler determination of right ventricular pressure: a simultaneous Doppler-catheterization study in 127 patients. J Am Coll Cardiol. 1985 Oct;6(4):750–756. doi: 10.1016/s0735-1097(85)80477-0. [DOI] [PubMed] [Google Scholar]
  10. Fisher J., Mack R. J., Likier H. M., Schiff A. N., Borer J. S. Nifedipine in pulmonary arterial hypertension. Importance of Raynaud's phenomenon. Chest. 1987 Sep;92(3):400–405. doi: 10.1378/chest.92.3.400. [DOI] [PubMed] [Google Scholar]
  11. Fishman A. P. Vasomotor regulation of the pulmonary circulation. Annu Rev Physiol. 1980;42:211–220. doi: 10.1146/annurev.ph.42.030180.001235. [DOI] [PubMed] [Google Scholar]
  12. GOLDRING R. M., FISHMAN A. P., TURINO G. M., COHEN H. I., DENNING C. R., ANDERSEN D. H. PULMONARY HYPERTENSION AND COR PULMONALE IN CYSTIC FIBROSIS OF THE PANCREAS. J Pediatr. 1964 Oct;65:501–524. doi: 10.1016/s0022-3476(64)80286-9. [DOI] [PubMed] [Google Scholar]
  13. Geggel R. L., Dozor A. J., Fyler D. C., Reid L. M. Effect of vasodilators at rest and during exercise in young adults with cystic fibrosis and chronic cor pulmonale. Am Rev Respir Dis. 1985 Apr;131(4):531–536. doi: 10.1164/arrd.1985.131.4.531. [DOI] [PubMed] [Google Scholar]
  14. Glazier J. B., Murray J. F. Sites of pulmonary vasomotor reactivity in the dog during alveolar hypoxia and serotonin and histamine infusion. J Clin Invest. 1971 Dec;50(12):2550–2558. doi: 10.1172/JCI106755. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Grant B. J. Effect of local pulmonary blood flow control on gas exchange: theory. J Appl Physiol Respir Environ Exerc Physiol. 1982 Nov;53(5):1100–1109. doi: 10.1152/jappl.1982.53.5.1100. [DOI] [PubMed] [Google Scholar]
  16. Green L. H., Smith T. W. The use of digitalis in patients with pulmonary disease. Ann Intern Med. 1977 Oct;87(4):459–465. doi: 10.7326/0003-4819-87-4-459. [DOI] [PubMed] [Google Scholar]
  17. HOWELL J. B., PERMUTT S., PROCTOR D. F., RILEY R. L. Effect of inflation of the lung on different parts of pulmonary vascular bed. J Appl Physiol. 1961 Jan;16:71–76. doi: 10.1152/jappl.1961.16.1.71. [DOI] [PubMed] [Google Scholar]
  18. Henry P. D. Comparative pharmacology of calcium antagonists: nifedipine, verapamil and diltiazem. Am J Cardiol. 1980 Dec 1;46(6):1047–1058. doi: 10.1016/0002-9149(80)90366-5. [DOI] [PubMed] [Google Scholar]
  19. Himelman R. B., Struve S. N., Brown J. K., Namnum P., Schiller N. B. Improved recognition of cor pulmonale in patients with severe chronic obstructive pulmonary disease. Am J Med. 1988 May;84(5):891–898. doi: 10.1016/0002-9343(88)90068-x. [DOI] [PubMed] [Google Scholar]
  20. Hirschfeld S. S., Fleming D. G., Doershuk C., Liebman J. Echocardiographic abnormalities in patients with cystic fibrosis. Chest. 1979 Mar;75(3):351–355. doi: 10.1378/chest.75.3.351. [DOI] [PubMed] [Google Scholar]
  21. Kambara H., Fujimoto K., Wakabayashi A., Kawai C. Primary pulmonary hypertension: beneficial therapy with diltiazem. Am Heart J. 1981 Feb;101(2):230–231. doi: 10.1016/0002-8703(81)90672-4. [DOI] [PubMed] [Google Scholar]
  22. Kelminson L. L., Cotton E. K., Vogel J. H. The reversibility of pulmonary hypertension in patients with cystic fibrosis. Observations on the effects of tolazoline hydrochloride. Pediatrics. 1967 Jan;39(1):24–35. [PubMed] [Google Scholar]
  23. Kennedy T., Summer W. Inhibition of hypoxic pulmonary vasoconstriction by nifedipine. Am J Cardiol. 1982 Oct;50(4):864–868. doi: 10.1016/0002-9149(82)91246-2. [DOI] [PubMed] [Google Scholar]
  24. Lebecque P., Lapierre J. G., Lamarre A., Coates A. L. Diffusion capacity and oxygen desaturation effects on exercise in patients with cystic fibrosis. Chest. 1987 May;91(5):693–697. doi: 10.1378/chest.91.5.693. [DOI] [PubMed] [Google Scholar]
  25. Liebman J., Doershuk C. F., Rapp C., Matthews L. The vectorcardiogram in cystic fibrosis. Diagnostic significance and correlation with pulmonary function tests. Circulation. 1967 Mar;35(3):552–569. doi: 10.1161/01.cir.35.3.552. [DOI] [PubMed] [Google Scholar]
  26. Lindemann H. Mukoviszidose und präkapilläre pulmonale Hypertonie. Monatsschr Kinderheilkd. 1987 Nov;135(11):728–734. [PubMed] [Google Scholar]
  27. Marchandise B., De Bruyne B., Delaunois L., Kremer R. Noninvasive prediction of pulmonary hypertension in chronic obstructive pulmonary disease by Doppler echocardiography. Chest. 1987 Mar;91(3):361–365. doi: 10.1378/chest.91.3.361. [DOI] [PubMed] [Google Scholar]
  28. Marshall B. E., Marshall C. Continuity of response to hypoxic pulmonary vasoconstriction. J Appl Physiol Respir Environ Exerc Physiol. 1980 Aug;49(2):189–196. doi: 10.1152/jappl.1980.49.2.189. [DOI] [PubMed] [Google Scholar]
  29. Matthay R. A., Berger H. J., Davies R., Loke J., Gottschalk A., Zaret B. L. Improvement in cardiac performance by oral long-acting theophylline in chronic obstructive pulmonary disease. Am Heart J. 1982 Nov;104(5 Pt 1):1022–1026. doi: 10.1016/0002-8703(82)90435-5. [DOI] [PubMed] [Google Scholar]
  30. Matthay R. A., Berger H. J., Loke J., Dolan T. F., Fagenholz S. A., Gottschalk A., Zaret B. L. Right and left ventricular performance in ambulatory young adults with cystic fibrosis. Br Heart J. 1980 Apr;43(4):474–480. doi: 10.1136/hrt.43.4.474. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Michael J. R., Kennedy T. P., Fitzpatrick S., Rosenstein B. J. Nifedipine inhibits hypoxic pulmonary vasoconstriction during rest and exercise in patients with cystic fibrosis and cor pulmonale. Am Rev Respir Dis. 1984 Sep;130(3):516–519. doi: 10.1164/arrd.1984.130.3.516. [DOI] [PubMed] [Google Scholar]
  32. Morin D. P., Cottrill C. M., Johnson G. L., Wilson H. D., Vine D. L., Noonan J. A. Effect of respiration on the echocardiogram in children with cystic fibrosis. Pediatrics. 1980 Jan;65(1):44–49. [PubMed] [Google Scholar]
  33. Moss A. J., Harper W. H., Dooley R. R., Murray J. F., Mack J. F. Cor pulmonale in cystic fibrosis of the pancreas. J Pediatr. 1965 Nov;67(5):797–807. doi: 10.1016/s0022-3476(65)80369-9. [DOI] [PubMed] [Google Scholar]
  34. Moss A. J. The cardiovascular system in cystic fibrosis. Pediatrics. 1982 Nov;70(5):728–741. [PubMed] [Google Scholar]
  35. NADAS A. S., COGAN G., LANDING B. H., SHWACHMAN H. Studies in pancreatic fibrosis; cor pulmonale: clinical and pathologic observations. Pediatrics. 1952 Sep;10(3):319–327. [PubMed] [Google Scholar]
  36. Panidis I. P., Ren J. F., Holsclaw D. S., Kotler M. N., Mintz G. S., Ross J. Cardiac function in patients with cystic fibrosis: evaluation by two-dimensional and Doppler echocardiography. J Am Coll Cardiol. 1985 Sep;6(3):701–706. doi: 10.1016/s0735-1097(85)80134-0. [DOI] [PubMed] [Google Scholar]
  37. Piepsz A., Ham H. R., Millet E., Dab I. Determination of right ventricular ejection fraction in children with cystic fibrosis. Pediatr Pulmonol. 1987 Jan-Feb;3(1):24–28. doi: 10.1002/ppul.1950030108. [DOI] [PubMed] [Google Scholar]
  38. ROYCE S. W. Cor pulmonale in infancy and early childhood; report on 34 patients, with special reference to the occurrence of pulmonary heart disease in cystic fibrosis of the pancreas. Pediatrics. 1951 Aug;8(2):255–274. [PubMed] [Google Scholar]
  39. Rosenthal A., Tucker C. R., Williams R. G., Khaw K. T., Strieder D., Shwachman H. Echocardiographic assessment of cor pulmonale in cystic fibrosis. Pediatr Clin North Am. 1976 May;23(2):327–344. doi: 10.1016/s0031-3955(16)33274-6. [DOI] [PubMed] [Google Scholar]
  40. Rubin L. J., Groves B. M., Reeves J. T., Frosolono M., Handel F., Cato A. E. Prostacyclin-induced acute pulmonary vasodilation in primary pulmonary hypertension. Circulation. 1982 Aug;66(2):334–338. doi: 10.1161/01.cir.66.2.334. [DOI] [PubMed] [Google Scholar]
  41. Rubin L. J., Nicod P., Hillis L. D., Firth B. G. Treatment of primary pulmonary hypertension with nifedipine. A hemodynamic and scintigraphic evaluation. Ann Intern Med. 1983 Oct;99(4):433–438. doi: 10.7326/0003-4819-99-4-433. [DOI] [PubMed] [Google Scholar]
  42. Ryssing E. Assessment of cor pulmonale in cystic fibrosis by echocardiography. Acta Paediatr Scand. 1977 Nov;66(6):753–756. doi: 10.1111/j.1651-2227.1977.tb07984.x. [DOI] [PubMed] [Google Scholar]
  43. Salzer-Muhar U., Burghuber O. C., Weissel M., Götz M. Nicht-invasive Beurteilung der pulmonalen Hypertension mit Hilfe gepulster Doppler-Sonographie bei erwachsenen Patienten mit zystischer Fibrose. Prax Klin Pneumol. 1988 Jul;42(7):580–582. [PubMed] [Google Scholar]
  44. Seeger W., Suttorp N. Role of membrane lipids in the pulmonary vascular abnormalities caused by bacterial toxins. Am Rev Respir Dis. 1987 Aug;136(2):462–466. doi: 10.1164/ajrccm/136.2.462. [DOI] [PubMed] [Google Scholar]
  45. Stern R. C., Borkat G., Hirschfeld S. S., Boat T. F., Matthews L. W., Liebman J., Doershuk C. F. Heart failure in cystic fibrosis. Treatment and prognosis of cor pulmonale with failure of the right side of the heart. Am J Dis Child. 1980 Mar;134(3):267–272. doi: 10.1001/archpedi.1980.02130150025007. [DOI] [PubMed] [Google Scholar]
  46. Stern R. C., Borkat G., Hirschfeld S. S., Boat T. F., Matthews L. W., Liebman J., Doershuk C. F. Heart failure in cystic fibrosis. Treatment and prognosis of cor pulmonale with failure of the right side of the heart. Am J Dis Child. 1980 Mar;134(3):267–272. doi: 10.1001/archpedi.1980.02130150025007. [DOI] [PubMed] [Google Scholar]
  47. Symchych P. S. Pulmonary hypertension in cystic fibrosis. A description and morphometric analysis of the pulmonary vasculature. Arch Pathol. 1971 Dec;92(6):409–414. [PubMed] [Google Scholar]
  48. Versteegh F. G., Neijens H. J., Bogaard J. M., Stam H., Robijn R. J., Kerrebijn K. F. Relationship between pulmonary function, O2 saturation during sleep and exercise, and exercise responses in children with cystic fibrosis. Adv Cardiol. 1986;35:151–155. doi: 10.1159/000413448. [DOI] [PubMed] [Google Scholar]
  49. Viles P. H., Shepherd J. T. Relationship between pH, Po2, and Pco2 on the pulmonary vascular bed of the cat. Am J Physiol. 1968 Nov;215(5):1170–1176. doi: 10.1152/ajplegacy.1968.215.5.1170. [DOI] [PubMed] [Google Scholar]
  50. Waring W. W., Matta E. G. Ventilation-blood flow relationships in cystic fibrosis: pulmonary "claustration". Am J Dis Child. 1968 Apr;115(4):420–427. doi: 10.1001/archpedi.1968.02100010422003. [DOI] [PubMed] [Google Scholar]
  51. Whitman V., Stern R. C., Bellet P., Doershuk C. F., Liebman J., Boat T. F., Borkat G., Matthews L. W. Studies on cor pulmonale in cystic fibrosis: I. Effects of diuresis. Pediatrics. 1975 Jan;55(1):83–85. [PubMed] [Google Scholar]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press

RESOURCES